Department of Radiology, University of Michigan, Ann Arbor, MI, USA; University of Michigan, Morris K Udall Center of Excellence for Parkinson's Disease Research, Ann Arbor, MI, USA.
Department of Radiology, University of Michigan, Ann Arbor, MI, USA; University of Michigan, Morris K Udall Center of Excellence for Parkinson's Disease Research, Ann Arbor, MI, USA.
Parkinsonism Relat Disord. 2018 Sep;54:46-50. doi: 10.1016/j.parkreldis.2018.04.006. Epub 2018 Apr 3.
Peripheral neuropathy is a common condition in the elderly that can affect balance and gait. Postural imbalance and gait difficulties in Parkinson's disease (PD), therefore, may stem not only from the primary neurodegenerative process but also from age-related medical comorbidities. Elucidation of the effects of peripheral neuropathy on these difficulties in PD is important to provide more targeted and effective therapy. The purpose of this study was to investigate the association between lower-limb peripheral neuropathy and falls and gait performance in PD while accounting for disease-specific factors.
From a total of 140 individuals with PD, 14 male participants met the criteria for peripheral neuropathy and were matched 1:1 for Hoehn & Yahr stage and duration of disease with 14 male participants without peripheral neuropathy. All participants underwent fall (retrospectively) and gait assessment, a clinical evaluation, and [C]dihydrotetrabenazine and [C]methylpiperidin-4-yl propionate PET imaging to assess dopaminergic and cholinergic denervation, respectively.
The presence of peripheral neuropathy was significantly associated with more falls (50% vs. 14%, p = 0.043), as well as a shorter stride length (p = 0.011) and greater stride length variability (p = 0.004), which resulted in slower gait speed (p = 0.016) during level walking. There was no significant difference in nigrostriatal dopaminergic denervation, cortical and thalamic cholinergic denervation, and MDS-UPDRS motor examination scores between groups.
Lower-limb peripheral neuropathy is significantly associated with more falls and gait difficulties in PD. Thus, treating such neuropathy may reduce falls and/or improve gait performance in PD.
周围神经病变是老年人常见的病症,可能会影响平衡和步态。因此,帕金森病(PD)患者的姿势失衡和步态困难不仅可能源于原发性神经退行性过程,还可能源于与年龄相关的医学合并症。阐明周围神经病变对 PD 患者这些困难的影响对于提供更有针对性和更有效的治疗方法很重要。本研究的目的是在考虑疾病特异性因素的情况下,研究下肢周围神经病变与 PD 患者跌倒和步态表现之间的关系。
从总共 140 名 PD 患者中,有 14 名男性参与者符合周围神经病变标准,并与 14 名男性无周围神经病变的患者按 Hoehn & Yahr 分期和疾病持续时间进行 1:1 匹配。所有参与者均接受了跌倒(回顾性)和步态评估、临床评估以及[C]二氢四苯并嗪和[C]甲基哌啶-4-基丙酸酯正电子发射断层扫描(PET)成像,以分别评估多巴胺能和胆碱能去神经支配。
周围神经病变的存在与更多跌倒(50%比 14%,p=0.043)显著相关,同时步长更短(p=0.011)和步长变异性更大(p=0.004),导致行走速度更慢(p=0.016)。两组间黑质纹状体多巴胺能去神经支配、皮质和丘脑胆碱能去神经支配以及 MDS-UPDRS 运动检查评分无显著差异。
下肢周围神经病变与 PD 患者更多跌倒和步态困难显著相关。因此,治疗这种周围神经病变可能会减少 PD 患者的跌倒次数和/或改善其步态表现。